Any topic (writer’s choice)
October 22, 2020
Research-based Marketing Plan Revised Final Proposal – Product Differentiation and Positioning Subject is Online High School
October 22, 2020
Show all

Week 10 Writing Assignment

During an inspection of New Drug Biologics, the FDA inspector observed multiple problems with documentation and quality oversight that are a violation of current good manufacturing practices (cGMPs). what is the process for notifying New Drug Biologics of these observations? How is New Drug Biologics able to respond after they have been notified of the observations?

If I were a competitor of New Drug Biologics, would I be able to find out what the FDA observed during the inspection? If so, how?

Leave a Reply

Your email address will not be published. Required fields are marked *